ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
ADAM10 | ADAM metallopeptidase domain 10 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM17 | ADAM metallopeptidase domain 17 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM2 | ADAM metallopeptidase domain 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM20 | ADAM metallopeptidase domain 20 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM21 | ADAM metallopeptidase domain 21 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS20 | ADAM metallopeptidase with thrombospondin type 1 motif, 20 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Not detected |
ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
AFG3L2 | AFG3-like AAA ATPase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AMZ2 | Archaelysin family metallopeptidase 2 | Enzymes
| | | | | Expressed in all |
ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
AQPEP | Aminopeptidase Q | Enzymes Predicted secreted proteins
| | | | | Group enriched |
BRCC3 | BRCA1/BRCA2-containing complex, subunit 3 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CNDP1 | Carnosine dipeptidase 1 (metallopeptidase M20 family) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CNDP2 | CNDP dipeptidase 2 (metallopeptidase M20 family) | Enzymes Plasma proteins
| | | | | Expressed in all |
COPS5 | COP9 signalosome subunit 5 | Enzymes
| | | | | Expressed in all |
COPS6 | COP9 signalosome subunit 6 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CPA1 | Carboxypeptidase A1 (pancreatic) | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CPA2 | Carboxypeptidase A2 (pancreatic) | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CPA3 | Carboxypeptidase A3 (mast cell) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CPB1 | Carboxypeptidase B1 (tissue) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CPE | Carboxypeptidase E | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CPQ | Carboxypeptidase Q | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
DNPEP | Aspartyl aminopeptidase | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
DPEP3 | Dipeptidase 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
DPP3 | Dipeptidyl-peptidase 3 | Enzymes Plasma proteins
| | | | | Expressed in all |
ECE1 | Endothelin converting enzyme 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ENPEP | Glutamyl aminopeptidase (aminopeptidase A) | CD markers Enzymes Plasma proteins
| | | | | Group enriched |
ERAP1 | Endoplasmic reticulum aminopeptidase 1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ERAP2 | Endoplasmic reticulum aminopeptidase 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
FOLH1 | Folate hydrolase (prostate-specific membrane antigen) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
IDE | Insulin-degrading enzyme | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
LAP3 | Leucine aminopeptidase 3 | Enzymes Plasma proteins
| | | | | Expressed in all |
LMLN | Leishmanolysin-like (metallopeptidase M8 family) | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
LTA4H | Leukotriene A4 hydrolase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MBTPS2 | Membrane-bound transcription factor peptidase, site 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
MEP1A | Meprin A, alpha (PABA peptide hydrolase) | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MEP1B | Meprin A, beta | Enzymes Predicted membrane proteins
| | | | | Group enriched |
METAP1 | Methionyl aminopeptidase 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
METAP1D | Methionyl aminopeptidase type 1D (mitochondrial) | Enzymes
| | | | | Expressed in all |
METAP2 | Methionyl aminopeptidase 2 | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
MIPEP | Mitochondrial intermediate peptidase | Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |